Eli Lilly (LLY)
Eli Lilly on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on NYSE, classified by the SEC as pharmaceutical preparations.
7.0M
Short interest
settlement 2026-10-15
3.0
Days to cover
+0.1 days vs prior
40.3%
Short share of volume
2026-10-28
308
Fails to deliver
settlement 2026-09-24
Thu 29 Oct
Next earnings
estimated date
-$16.0M
Insider flow, 90 days
0 buys, 3 sells
As of 2026-10-28.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in LLY is 6,960,837 shares, down 559,081 shares over the last month. Over the last 48 readings it ranged from 5,791,186 shares (13 December 2024) to 10,278,892 shares (15 July 2026). At the reported average volume of 2.3M shares a day that is 3.0 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/lly" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 6,960,837 | -1.1% | 2,286,458 | 3.04 |
| 2026-09-30 | 7,035,434 | -6.4% | 2,400,203 | 2.93 |
| 2026-09-15 | 7,519,918 | -4.7% | 2,204,573 | 3.41 |
| 2026-08-31 | 7,894,476 | +20.3% | 2,640,226 | 2.99 |
| 2026-08-14 | 6,564,742 | -28.0% | 3,106,628 | 2.11 |
| 2026-07-31 | 9,117,184 | -11.3% | 2,316,357 | 3.94 |
| 2026-07-15 | 10,278,892 | +9.9% | 2,527,511 | 4.07 |
| 2026-06-30 | 9,353,153 | -3.2% | 3,624,842 | 2.58 |
| 2026-06-15 | 9,662,739 | -1.4% | 3,211,646 | 3.01 |
| 2026-05-29 | 9,795,475 | +16.2% | 3,307,630 | 2.96 |
| 2026-05-15 | 8,430,505 | +7.2% | 3,326,719 | 2.53 |
| 2026-04-30 | 7,862,175 | -3.1% | 3,521,025 | 2.23 |
| 2026-04-15 | 8,114,678 | +5.3% | 2,842,565 | 2.85 |
| 2026-03-31 | 7,704,068 | +12.1% | 3,131,283 | 2.46 |
| 2026-03-13 | 6,873,427 | +1.3% | 2,454,629 | 2.80 |
| 2026-02-27 | 6,785,689 | +6.4% | 3,184,626 | 2.13 |
| 2026-02-13 | 6,379,120 | -8.6% | 4,384,383 | 1.45 |
| 2026-01-30 | 6,981,558 | -9.3% | 2,879,996 | 2.42 |
| 2026-01-15 | 7,697,492 | +10.4% | 3,028,579 | 2.54 |
| 2025-12-31 | 6,970,774 | +6.5% | 2,605,596 | 2.68 |
| 2025-12-15 | 6,547,749 | -7.4% | 3,383,572 | 1.94 |
| 2025-11-28 | 7,073,265 | -2.4% | 3,847,630 | 1.84 |
| 2025-11-14 | 7,247,713 | +12.6% | 5,244,081 | 1.38 |
| 2025-10-31 | 6,436,275 | -6.0% | 3,138,460 | 2.05 |
| 2025-10-15 | 6,843,231 | -11.0% | 3,718,380 | 1.84 |
| 2025-09-30 | 7,686,850 | +5.0% | 4,007,818 | 1.92 |
| 2025-09-15 | 7,323,001 | -8.9% | 2,901,226 | 2.52 |
| 2025-08-29 | 8,041,246 | -7.5% | 4,250,575 | 1.89 |
| 2025-08-15 | 8,696,819 | +21.3% | 8,905,155 | 1.00 |
| 2025-07-31 | 7,172,654 | -6.2% | 3,713,304 | 1.93 |
| 2025-07-15 | 7,643,653 | -0.9% | 2,730,406 | 2.80 |
| 2025-06-30 | 7,714,191 | -3.8% | 3,438,896 | 2.24 |
| 2025-06-13 | 8,016,527 | -0.1% | 3,000,543 | 2.67 |
| 2025-05-30 | 8,028,911 | +9.3% | 3,916,150 | 2.05 |
| 2025-05-15 | 7,348,411 | -0.1% | 6,186,930 | 1.19 |
| 2025-04-30 | 7,352,058 | +14.4% | 3,990,822 | 1.84 |
| 2025-04-15 | 6,425,144 | -8.4% | 4,032,737 | 1.59 |
| 2025-03-31 | 7,016,170 | +10.3% | 3,216,944 | 2.18 |
| 2025-03-14 | 6,361,775 | -12.1% | 3,796,675 | 1.68 |
| 2025-02-28 | 7,237,706 | +2.2% | 3,638,137 | 1.99 |
| 2025-02-14 | 7,081,854 | +4.7% | 3,649,087 | 1.94 |
| 2025-01-31 | 6,767,383 | -6.3% | 3,504,181 | 1.93 |
| 2025-01-15 | 7,221,237 | +18.4% | 4,283,739 | 1.69 |
| 2024-12-31 | 6,098,698 | +5.3% | 3,353,556 | 1.82 |
| 2024-12-13 | 5,791,186 | -0.8% | 3,028,463 | 1.91 |
| 2024-11-29 | 5,836,746 | -10.8% | 5,059,888 | 1.15 |
| 2024-11-15 | 6,543,322 | -1.2% | 4,914,543 | 1.33 |
| 2024-10-31 | 6,624,655 | +14.5% | 3,824,266 | 1.73 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 28 October 2026, the short share of LLY volume is 40.3%, down 7.8 points over the last five sessions. Over the last 30 readings it ranged from 33.2% (27 October 2026) to 59.5% (30 September 2026). The latest reading is 7.0 points below the 30-session average of 47.2%, on 779K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-28 | 314K | 779K | 40.3% | 25 |
| 2026-10-27 | 259K | 780K | 33.2% | 325 |
| 2026-10-26 | 499K | 877K | 56.9% | 1,416 |
| 2026-10-23 | 333K | 906K | 36.7% | 2,662 |
| 2026-10-22 | 563K | 1.1M | 51.6% | 150 |
| 2026-10-21 | 351K | 731K | 48.0% | 161 |
| 2026-10-20 | 697K | 1.4M | 48.8% | 529 |
| 2026-10-19 | 281K | 621K | 45.3% | 1,067 |
| 2026-10-16 | 564K | 1.0M | 55.3% | 600 |
| 2026-10-15 | 702K | 1.7M | 40.5% | 621 |
| 2026-10-14 | 586K | 1.3M | 45.2% | 2,889 |
| 2026-10-13 | 307K | 726K | 42.3% | 100 |
| 2026-10-12 | 246K | 508K | 48.5% | 2,248 |
| 2026-10-09 | 259K | 589K | 43.9% | 28 |
| 2026-10-08 | 696K | 1.2M | 56.5% | 1,314 |
| 2026-10-07 | 494K | 1.0M | 47.3% | 10 |
| 2026-10-06 | 439K | 882K | 49.8% | 456 |
| 2026-10-05 | 317K | 705K | 44.9% | 317 |
| 2026-10-02 | 370K | 743K | 49.8% | 12 |
| 2026-10-01 | 384K | 885K | 43.4% | 882 |
| 2026-09-30 | 705K | 1.2M | 59.5% | 91 |
| 2026-09-29 | 322K | 645K | 49.9% | 2,113 |
| 2026-09-28 | 312K | 646K | 48.2% | 146 |
| 2026-09-25 | 364K | 765K | 47.5% | 957 |
| 2026-09-24 | 423K | 996K | 42.5% | 628 |
| 2026-09-23 | 396K | 760K | 52.2% | 958 |
| 2026-09-22 | 490K | 1.1M | 46.4% | 268 |
| 2026-09-21 | 369K | 745K | 49.6% | 34 |
| 2026-09-18 | 293K | 589K | 49.7% | 788 |
| 2026-09-17 | 252K | 584K | 43.2% | 8 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 24 September 2026, the fails-to-deliver balance in LLY is 308 shares, down 4,389 shares over the last settlement date. Over the last 30 readings it ranged from 40 shares (10 July 2026) to 12,307 shares (29 June 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-24 | 308 | $1150.99 | $355K |
| 2026-09-23 | 4,697 | $1170.14 | $5.5M |
| 2026-09-18 | 1,061 | $1152.44 | $1.2M |
| 2026-09-14 | 857 | $1115.70 | $956K |
| 2026-09-11 | 173 | $1123.00 | $194K |
| 2026-09-09 | 997 | $1123.91 | $1.1M |
| 2026-09-04 | 244 | $1159.60 | $283K |
| 2026-08-31 | 85 | $1174.61 | $100K |
| 2026-08-24 | 2,914 | $1255.40 | $3.7M |
| 2026-08-19 | 986 | $1225.73 | $1.2M |
| 2026-08-17 | 78 | $1180.16 | $92K |
| 2026-08-14 | 2,681 | $1209.00 | $3.2M |
| 2026-08-12 | 416 | $1215.02 | $505K |
| 2026-08-11 | 193 | $1231.94 | $238K |
| 2026-08-10 | 8,965 | $1185.71 | $10.6M |
| 2026-08-07 | 270 | $1191.94 | $322K |
| 2026-08-06 | 270 | $1169.86 | $316K |
| 2026-07-30 | 821 | $1210.02 | $993K |
| 2026-07-29 | 984 | $1220.66 | $1.2M |
| 2026-07-27 | 259 | $1196.03 | $310K |
| 2026-07-20 | 2,581 | $1179.11 | $3.0M |
| 2026-07-15 | 338 | $1152.54 | $390K |
| 2026-07-10 | 40 | $1216.95 | $49K |
| 2026-07-09 | 155 | $1215.83 | $188K |
| 2026-07-07 | 1,890 | $1200.06 | $2.3M |
| 2026-06-29 | 12,307 | $1208.12 | $14.9M |
| 2026-06-23 | 855 | $1102.08 | $942K |
| 2026-06-17 | 2,051 | $1122.50 | $2.3M |
| 2026-06-15 | 3,499 | $1133.00 | $4.0M |
| 2026-06-11 | 490 | $1136.37 | $557K |
Insider trades
SEC Form 4, newest first. JSONInsiders at LLY reported 3 open-market sells worth $16.0M in the last 90 days and no open-market buys. Latest filing: Sulzberger Gabrielle (Director) on 2026-10-19.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-19 | Sulzberger Gabrielle | Director | Grant | 4 | $1240.34 | $5K | 3K |
| 2026-10-19 | LUCIANO JUAN R | Director | Grant | 13 | $1240.34 | $16K | 17K |
| 2026-10-19 | Fyrwald J Erik | Director | Grant | 8 | $1240.34 | $10K | 76K |
| 2026-10-19 | Alvarez Ralph | Director | Grant | 10 | $1240.34 | $12K | 56K |
| 2026-09-21 | Sulzberger Gabrielle | Director | Grant | 4 | $1164.89 | $5K | 3K |
| 2026-09-21 | LUCIANO JUAN R | Director | Grant | 14 | $1164.89 | $16K | 17K |
| 2026-09-21 | Fyrwald J Erik | Director | Grant | 9 | $1164.89 | $10K | 76K |
| 2026-09-21 | Alvarez Ralph | Director | Grant | 11 | $1164.89 | $12K | 56K |
| 2026-09-09 | Seymour Melissa | EVP, Global Quality | Gift | 12 | $0.00 | $0 | 1K |
| 2026-09-02 | Hernandez Edgardo | EVP & Pres., Mfg. Operations | Gift | 13 | $0.00 | $0 | 46K |
| 2026-09-02 | Dozier Eric | EVP, Chief People Officer | Gift | 216 | $0.00 | $0 | 14K |
| 2026-08-17 | Jonsson Patrik | EVP & President, LLY Int'l | Sell | 7K | $1175.10 | $7.6M | 54K |
| 2026-08-17 | Sulzberger Gabrielle | Director | Grant | 4 | $1183.16 | $5K | 3K |
| 2026-08-17 | LUCIANO JUAN R | Director | Grant | 13 | $1183.16 | $16K | 17K |
| 2026-08-17 | Fyrwald J Erik | Director | Grant | 8 | $1183.16 | $10K | 75K |
| 2026-08-17 | Alvarez Ralph | Director | Grant | 10 | $1183.16 | $12K | 56K |
| 2026-08-10 | Zakrowski Donald A | SVP, Finance, & CAO | Sell | 2K | $1185.01 | $2.4M | 2K |
| 2026-08-07 | Hakim Anat | EVP, GC & Secretary | Sell | 5K | $1190.00 | $6.0M | 12K |
| 2026-08-01 | Seymour Melissa | EVP, Global Quality | Tax withholding | 439 | $1148.84 | $504K | 1K |
| 2026-08-01 | Seymour Melissa | EVP, Global Quality | Exercise or conversion | 981 | $0.00 | $0 | 2K |
| 2026-07-20 | Sulzberger Gabrielle | Director | Grant | 4 | $1146.90 | $5K | 3K |
| 2026-07-20 | LUCIANO JUAN R | Director | Grant | 14 | $1146.90 | $16K | 17K |
| 2026-07-20 | Fyrwald J Erik | Director | Grant | 9 | $1146.90 | $10K | 75K |
| 2026-07-20 | Alvarez Ralph | Director | Grant | 11 | $1146.90 | $12K | 56K |
| 2026-06-15 | Alvarez Ralph | Director | Grant | 11 | $1129.35 | $12K | 56K |
| 2026-06-15 | Fyrwald J Erik | Director | Grant | 9 | $1129.35 | $10K | 75K |
| 2026-06-15 | LUCIANO JUAN R | Director | Grant | 14 | $1129.35 | $16K | 17K |
| 2026-06-15 | Sulzberger Gabrielle | Director | Grant | 4 | $1129.35 | $5K | 3K |
| 2026-06-15 | Alvarez Ralph | Director | Grant | 11 | $1129.35 | $12K | 56K |
| 2026-06-10 | Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | Sell | 3K | $1150.77 | $2.9M | 30K |
| 2026-05-18 | Alvarez Ralph | Director | Grant | 13 | $988.09 | $12K | 56K |
| 2026-05-18 | Fyrwald J Erik | Director | Grant | 10 | $988.09 | $10K | 75K |
| 2026-05-18 | LUCIANO JUAN R | Director | Grant | 16 | $988.09 | $16K | 17K |
| 2026-05-18 | Sulzberger Gabrielle | Director | Grant | 5 | $988.09 | $5K | 3K |
| 2026-05-18 | Sulzberger Gabrielle | Director | Grant | 5 | $988.09 | $5K | 3K |
| 2026-05-18 | LUCIANO JUAN R | Director | Grant | 16 | $988.09 | $16K | 17K |
| 2026-05-18 | Fyrwald J Erik | Director | Grant | 10 | $988.09 | $10K | 75K |
| 2026-05-18 | Alvarez Ralph | Director | Grant | 13 | $988.09 | $12K | 56K |
| 2026-05-06 | LILLY ENDOWMENT INC | Former 10% Shareholder | Sell | 2K | $996.18 | $2.2M | 91.9M |
| 2026-05-06 | LILLY ENDOWMENT INC | Former 10% Shareholder | Sell | 14K | $995.23 | $13.6M | 91.9M |
| 2026-04-20 | Alvarez Ralph | Director | Grant | 14 | $919.90 | $12K | 56K |
| 2026-04-20 | LUCIANO JUAN R | Director | Grant | 17 | $919.90 | $16K | 17K |
| 2026-04-20 | Sulzberger Gabrielle | Director | Grant | 5 | $919.90 | $5K | 3K |
| 2026-04-20 | LUCIANO JUAN R | Director | Grant | 17 | $919.90 | $16K | 17K |
| 2026-04-20 | Fyrwald J Erik | Director | Grant | 11 | $919.90 | $10K | 75K |
| 2026-04-20 | Alvarez Ralph | Director | Grant | 13 | $919.90 | $12K | 56K |
| 2026-03-16 | Alvarez Ralph | Director | Grant | 13 | $989.12 | $12K | 56K |
| 2026-03-16 | Fyrwald J Erik | Director | Grant | 10 | $989.12 | $10K | 75K |
| 2026-03-16 | LUCIANO JUAN R | Director | Grant | 16 | $989.12 | $16K | 17K |
| 2026-03-16 | Sulzberger Gabrielle | Director | Grant | 5 | $989.12 | $5K | 3K |
| 2026-03-16 | Sulzberger Gabrielle | Director | Grant | 5 | $989.12 | $5K | 3K |
| 2026-03-16 | LUCIANO JUAN R | Director | Grant | 16 | $989.12 | $16K | 17K |
| 2026-03-16 | Fyrwald J Erik | Director | Grant | 10 | $989.12 | $10K | 75K |
| 2026-03-16 | Alvarez Ralph | Director | Grant | 13 | $989.12 | $12K | 56K |
| 2026-02-19 | Dozier Eric | EVP, Chief People Officer | Gift | 481 | $0.00 | $0 | 14K |
| 2026-02-17 | Alvarez Ralph | Director | Grant | 12 | $1036.05 | $12K | 55K |
| 2026-02-17 | Fyrwald J Erik | Director | Grant | 10 | $1036.05 | $10K | 75K |
| 2026-02-17 | LUCIANO JUAN R | Director | Grant | 15 | $1036.05 | $16K | 17K |
| 2026-02-17 | Sulzberger Gabrielle | Director | Grant | 5 | $1036.05 | $5K | 3K |
| 2026-02-17 | Sulzberger Gabrielle | Director | Grant | 5 | $1036.05 | $5K | 3K |
| 2026-02-17 | LUCIANO JUAN R | Director | Grant | 15 | $1036.05 | $16K | 17K |
| 2026-02-17 | Fyrwald J Erik | Director | Grant | 10 | $1036.05 | $10K | 75K |
| 2026-02-17 | Alvarez Ralph | Director | Grant | 12 | $1036.05 | $12K | 55K |
| 2026-02-16 | Brown Adrienne S | EVP, President LLY Imm | Tax withholding | 170 | $1040.00 | $177K | 5K |
| 2026-02-16 | Custer Kenneth L. | EVP & President, Card Met Hlth | Tax withholding | 91 | $1040.00 | $95K | 10K |
| 2026-02-16 | Montarce Lucas | EVP & CFO | Tax withholding | 160 | $1040.00 | $166K | 16K |
| 2026-02-16 | Zakrowski Donald A | SVP, Finance, & CAO | Tax withholding | 82 | $1040.00 | $85K | 4K |
| 2026-02-16 | Montarce Lucas | EVP & CFO | Tax withholding | 160 | $1040.00 | $166K | 16K |
| 2026-02-16 | Montarce Lucas | EVP & CFO | Exercise or conversion | 368 | $0.00 | $0 | 16K |
| 2026-02-16 | Zakrowski Donald A | SVP, Finance, & CAO | Tax withholding | 82 | $1040.00 | $85K | 4K |
| 2026-02-16 | Zakrowski Donald A | SVP, Finance, & CAO | Exercise or conversion | 184 | $0.00 | $0 | 4K |
| 2026-02-16 | Custer Kenneth L. | EVP & President, Card Met Hlth | Tax withholding | 91 | $1040.00 | $95K | 10K |
| 2026-02-16 | Custer Kenneth L. | EVP & President, Card Met Hlth | Exercise or conversion | 207 | $0.00 | $0 | 10K |
| 2026-02-16 | Brown Adrienne S | EVP, President LLY Imm | Tax withholding | 170 | $1040.00 | $177K | 5K |
| 2026-02-16 | Brown Adrienne S | EVP, President LLY Imm | Exercise or conversion | 391 | $0.00 | $0 | 5K |
| 2026-02-09 | Brown Adrienne S | EVP, President LLY Imm | Grant | 1K | $1044.67 | $1.2M | 5K |
| 2026-02-09 | Dozier Eric | EVP, Chief People Officer | Grant | 4K | $1044.67 | $3.7M | 15K |
| 2026-02-09 | Hakim Anat | EVP, GC & Secretary | Grant | 8K | $1044.67 | $8.6M | 23K |
| 2026-02-09 | Hernandez Edgardo | EVP & Pres., Mfg. Operations | Grant | 4K | $1044.67 | $4.6M | 46K |
| 2026-02-09 | Jonsson Patrik | EVP & President, LLY Int'l | Grant | 5K | $1044.67 | $5.0M | 61K |
| 2026-02-09 | Ricks David A | President, Chair, and CEO | Grant | 39K | $1044.67 | $40.7M | 572K |
| 2026-02-09 | Skovronsky Daniel | EVP, CS&PO & Pres. LRL | Grant | 16K | $1044.67 | $16.2M | 160K |
| 2026-02-09 | Van Naarden Jacob | EVP,Pres LLY Oncology&HdCorpBD | Grant | 5K | $1044.67 | $5.1M | 27K |
| 2026-02-09 | Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | Grant | 4K | $1044.67 | $4.3M | 32K |
| 2026-02-09 | Zakrowski Donald A | SVP, Finance, & CAO | Grant | 584 | $1044.67 | $610K | 3K |
| 2026-02-09 | Rau Diogo | EVP & CIDO | Grant | 5K | $1044.67 | $4.8M | 26K |
| 2026-02-09 | Hernandez Edgardo | EVP & Pres., Mfg. Operations | Grant | 4K | $1044.67 | $4.6M | 46K |
| 2026-02-09 | Rau Diogo | EVP & CIDO | Grant | 4K | $1044.67 | $4.6M | 26K |
| 2026-02-09 | Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | Grant | 4K | $1044.67 | $4.3M | 32K |
| 2026-02-09 | Jonsson Patrik | EVP & President, LLY Int'l | Grant | 5K | $1044.67 | $5.0M | 61K |
| 2026-02-09 | Montarce Lucas | EVP & CFO | Grant | 1K | $1044.67 | $1.4M | 16K |
| 2026-02-09 | Skovronsky Daniel | EVP, CS&PO & Pres. LRL | Grant | 16K | $1044.67 | $16.2M | 160K |
| 2026-02-09 | Hakim Anat | EVP, GC & Secretary | Grant | 8K | $1044.67 | $8.6M | 23K |
| 2026-02-09 | Van Naarden Jacob | EVP,Pres LLY Oncology&HdCorpBD | Grant | 5K | $1044.67 | $5.1M | 27K |
| 2026-02-09 | Zakrowski Donald A | SVP, Finance, & CAO | Grant | 584 | $1044.67 | $610K | 3K |
| 2026-02-09 | Ricks David A | President, Chair, and CEO | Grant | 39K | $1044.67 | $40.7M | 572K |
| 2026-02-09 | Dozier Eric | EVP, Chief People Officer | Grant | 4K | $1044.67 | $3.7M | 15K |
| 2026-02-09 | Custer Kenneth L. | EVP & President, Card Met Hlth | Grant | 659 | $1044.67 | $689K | 10K |
| 2026-02-09 | Brown Adrienne S | EVP, President LLY Imm | Grant | 1K | $1044.67 | $1.2M | 5K |
| 2026-02-01 | Dozier Eric | EVP, Chief People Officer | Tax withholding | 1K | $1037.15 | $1.3M | 11K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON24 Form 144 notices on file for LLY worth $6.22B at the prices reported; 4 in the last 90 days worth $730.2M. Latest: LILLY ENDOWMENT, INC. filed on 2026-10-15 to sell 305,000 shares ($368.7M) from 2026-10-15.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-10-15 | LILLY ENDOWMENT, INC.Shareholder | 305K | $368.7M | 0.032% | 2026-10-15 | Fidelity Capital Markets |
| 2026-10-07 | LILLY ENDOWMENT, INC.Shareholder | 300K | $347.2M | 0.032% | 2026-10-07 | J.P. Morgan Securities LLC |
| 2026-08-10 | DONALD ZAKROWSKIOfficer | 2K | $2.4M | 0.000% | 2026-08-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-07 | Hakim AnatOfficer | 10K | $11.9M | 0.001% | 2026-08-07 | THE CHARLES SCHWAB CORPORATION |
| 2026-07-07 | LILLY ENDOWMENT, INC.Shareholder | 310K | $372.0M | 0.033% | 2026-07-07 | Fidelity Capital Markets |
| 2026-06-26 | LILLY ENDOWMENT, INC.Shareholder | 305K | $343.9M | 0.032% | 2026-06-26 | J.P. Morgan Securities LLC |
| 2026-06-10 | Yuffa IlyaOfficer | 3K | $2.9M | 0.000% | 2026-06-10 | THE CHARLES SCHWAB CORPORATION |
| 2026-05-28 | LILLY ENDOWMENT, INC.Shareholder | 310K | $335.7M | 0.033% | 2026-05-28 | Fidelity Capital Markets |
| 2026-05-22 | LILLY ENDOWMENT, INC.Shareholder | 300K | $312.5M | 0.032% | 2026-05-22 | J.P. Morgan Securities LLC |
| 2026-05-20 | LILLY ENDOWMENT, INC.Shareholder | 305K | $311.5M | 0.032% | 2026-05-20 | Fidelity Capital Markets |
| 2026-05-06 | LILLY ENDOWMENT, INC.Shareholder | 300K | $296.7M | 0.032% | 2026-05-06 | J.P. Morgan Securities LLC |
| 2025-12-23 | LILLY ENDOWMENT, INC.10% Stockholder | 300K | $322.9M | 0.032% | 2025-12-23 | Fidelity Capital Markets |
| 2025-11-24 | LILLY ENDOWMENT, INC.10% Stockholder | 305K | $323.2M | 0.032% | 2025-11-24 | Fidelity Capital Markets |
| 2025-11-19 | LILLY ENDOWMENT, INC.10% Stockholder | 310K | $319.3M | 0.033% | 2025-11-19 | J.P. Morgan Securities LLC |
| 2025-11-13 | LILLY ENDOWMENT, INC.10% Stockholder | 295K | $300.2M | 0.031% | 2025-11-13 | Fidelity Capital Markets |
| 2025-11-12 | LILLY ENDOWMENT, INC.10% Stockholder | 305K | $301.5M | 0.032% | 2025-11-12 | J.P. Morgan Securities LLC |
| 2025-11-10 | LILLY ENDOWMENT, INC.10% Stockholder | 300K | $277.3M | 0.032% | 2025-11-10 | Fidelity Capital Markets |
| 2025-11-04 | LILLY ENDOWMENT, INC.10% Stockholder | 220K | $197.2M | 0.023% | 2025-11-04 | J.P. Morgan Securities LLC |
| 2025-11-03 | LILLY ENDOWMENT, INC.10% Stockholder | 300K | $258.9M | 0.032% | 2025-11-03 | Fidelity Capital Markets |
| 2025-10-10 | LILLY ENDOWMENT INC10% Stockholder | 305K | $260.9M | 0.032% | 2025-10-10 | J.P. Morgan Securities LLC |
| 2025-10-06 | LILLY ENDOWMENT INC10% Stockholder | 300K | $252.0M | 0.032% | 2025-10-06 | Fidelity Capital Markets |
| 2025-10-02 | LILLY ENDOWMENT INC10% Stockholder | 305K | $251.8M | 0.032% | 2025-10-02 | J.P. Morgan Securities LLC |
| 2025-10-01 | LILLY ENDOWMENT INC10% Stockholder | 295K | $225.1M | 0.031% | 2025-10-01 | Fidelity Capital Markets |
| 2025-09-18 | LILLY ENDOWMENT INC10% Stockholder | 300K | $228.0M | 0.032% | 2025-09-18 | J.P. Morgan Securities LLC |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON2 holders report 5% or more of LLY in their latest filing, all on Schedule 13G (passive). The largest reported stake is LILLY ENDOWMENT, INC. at 9.6% of the class (90,066,978 shares), filed 2026-10-19 for an event on 2026-09-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-19 | 13G/Ano. 47 | LILLY ENDOWMENT, INC.corporation | 90.1M | 9.6% | 2026-09-30 |
| 2026-05-01 | 13G | Vanguard Capital Managementinvestment adviser | 61.3M | 6.5% | 2026-03-31 |
| 2026-03-26 | 13G/Ano. 10 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
13F holders
Tracked managers holding LLY at their latest 13F. JSON12 of the 30 tracked managers held LLY at their latest 13F, $9.64B in total at quarter-end prices. Fisher Asset Management is the largest at $6.07B (1.8% of its portfolio) as of 2026-06-30. Over the prior quarter 7 added shares and 4 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Fisher Asset Management | 2026-06-30 | 5.1M | $6.07B | 1.81% | +225K |
| AQR Capital Management | 2026-06-30 | 1.0M | $1.24B | 0.43% | +180K |
| Citadel Advisors | 2026-06-30 | 945K | $1.13B | 0.13% | +704K |
| D. E. Shaw & Co. | 2026-06-30 | 497K | $595.6M | 0.28% | -141K |
| Millennium Management | 2026-06-30 | 183K | $219.1M | 0.08% | -93K |
| Bridgewater Associates | 2026-06-30 | 87K | $104.4M | 0.43% | +16K |
| Two Sigma Investments | 2026-06-30 | 81K | $97.4M | 0.07% | +17K |
| ARK Investment Management | 2026-06-30 | 77K | $92.7M | 0.60% | +65K |
| Renaissance Technologies | 2026-06-30 | 26K | $31.3M | 0.04% | -46K |
| Soros Fund Management | 2026-06-30 | 22K | $26.6M | 0.33% | 0 |
| Duquesne Family Office | 2026-06-30 | 12K | $14.8M | 0.28% | new |
| Point72 Asset Management | 2026-06-30 | 10K | $12.6M | 0.01% | -85K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Eli Lilly reported revenue of $22.97B, up 47.7% from the same quarter a year earlier, and net income of $7.09B (7.94 diluted EPS). In FY 2025 it generated $16.81B of operating cash flow and spent $4.11B on buybacks and $5.38B on dividends. As of 2026-06-30, cash was $8.95B against $54.91B of debt.
- Cash
- $8.95B
- Debt
- $54.91B
- Equity
- $33.88B
- Total assets
- $142.28B
- Shares outstanding
- 941,357,065
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $22.97B | $7.09B | 30.9% | 7.94 |
| Q1 FY 2026 | 2026-03-31 | $19.80B | $7.40B | 37.4% | 8.26 |
| Q4 FY 2025derived | 2025-12-31 | $19.29B | $6.64B | 34.4% | n/a |
| Q3 FY 2025 | 2025-09-30 | $17.60B | $5.58B | 31.7% | 6.21 |
| Q2 FY 2025 | 2025-06-30 | $15.56B | $5.66B | 36.4% | 6.29 |
| Q1 FY 2025 | 2025-03-31 | $12.73B | $2.76B | 21.7% | 3.06 |
| Q4 FY 2024derived | 2024-12-31 | $13.53B | $4.41B | 32.6% | n/a |
| Q3 FY 2024 | 2024-09-30 | $11.44B | $970.3M | 8.5% | 1.07 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $65.18B | $20.64B | $16.81B | $7.84B | $4.11B | $5.38B |
| FY 2024 | 2024-12-31 | $45.04B | $10.59B | $8.82B | $5.06B | $2.50B | $4.68B |
| FY 2023 | 2023-12-31 | $34.12B | $5.24B | $4.24B | $3.45B | $750.0M | $4.07B |
| FY 2022 | 2022-12-31 | $28.54B | $6.24B | $7.59B | $1.85B | $1.50B | $3.54B |
| FY 2021 | 2021-12-31 | $28.32B | $5.58B | $7.37B | $1.31B | $1.25B | $3.09B |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-08-03 from the cover page.
What this page is
Eli Lilly in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Eli Lilly (LLY), SEC CIK 59478, listed on NYSE, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-28.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-24.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-10-15.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-19.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-05.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-19.JSON and CSV
- Company record
- EDGAR filing index for CIK 59478Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
- BLDRBuilders FirstSource
- BLKBlackRock
- BMNRBitMine Immersion Technologies
- BMRNBiomarin Pharmaceutical
- BNBrookfield
- BNOUnited States Brent Oil Fund
- BNSBank of Nova Scotia
- BNYBank of New York Mellon
- BRBroadridge Financial Solutions
- BRK-BBerkshire Hathaway
- BRKRBruker
- BROBrown & Brown
- BROSDutch Bros
- BSXBoston Scientific
- BTGB2Gold
- BTIBritish American Tobacco
Datasets
Frequently Asked Questions
How much of LLY is sold short?
6,960,837 shares were held short at the 2026-10-15 settlement, 3.0 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is LLY's daily short volume?
On 2026-10-28, 313,526 of the 778,980 LLY shares reported to FINRA were sold short, 40.3% of the day's reported volume. Short volume is a flow for one day, not a position.
Does LLY have fails to deliver?
The SEC's latest file shows 308 LLY shares failed to deliver at settlement 2026-09-24. Fails are reported per settlement date and published twice a month with a lag.
Are LLY insiders buying or selling?
Insiders at LLY reported 3 open-market sells worth $16.0M in the last 90 days and no open-market buys. Latest filing: Sulzberger Gabrielle (Director) on 2026-10-19.
Have LLY insiders filed to sell?
24 Form 144 notices on file for LLY worth $6.22B at the prices reported; 4 in the last 90 days worth $730.2M. Latest: LILLY ENDOWMENT, INC. filed on 2026-10-15 to sell 305,000 shares ($368.7M) from 2026-10-15.
Who owns 5% or more of LLY?
2 holders report 5% or more of LLY in their latest filing, all on Schedule 13G (passive). The largest reported stake is LILLY ENDOWMENT, INC. at 9.6% of the class (90,066,978 shares), filed 2026-10-19 for an event on 2026-09-30.
What did LLY report last quarter?
In Q2 FY 2026 (quarter ended 2026-06-30) Eli Lilly reported revenue of $22.97B, up 47.7% from the same quarter a year earlier, and net income of $7.09B (7.94 diluted EPS). In FY 2025 it generated $16.81B of operating cash flow and spent $4.11B on buybacks and $5.38B on dividends. As of 2026-06-30, cash was $8.95B against $54.91B of debt.
Which tracked 13F managers own LLY?
12 of the 30 tracked 13F managers held LLY shares at their latest filing, $9.64B in all. The largest: Ken Fisher's Fisher Asset Management (5.1M shares, $6.07B), Cliff Asness's AQR Capital Management (1.0M shares, $1.24B), Ken Griffin's Citadel Advisors (945K shares, $1.13B), D. E. Shaw & Co. (497K shares, $595.6M), Izzy Englander's Millennium Management (183K shares, $219.1M), Ray Dalio's Bridgewater Associates (87K shares, $104.4M). The table above lists all 12.
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.